In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Advocacy Committee and Regulatory Affairs Committee

2020-2022

The ESC is dedicated to reducing the burden of cardiovascular disease by advancing cardiovascular science, supporting high quality healthcare and promoting evidence-based decision making. To this end, the cardiology and cardiovascular science profession needs to interact, via policies and partners, with decisionmakers in healthcare as well as the patients, in order to provide expert advice and support.

The ESC advocacy committee`s overarching goal is to provide a platform to implement and coordinate these activities, to engage in a permanent dialogue with European and national policy makers and to ultimately serve the mission of the ESC to “reduce the burden of cardiovascular disease”.

Within this framework, the ESC Regulatory Affairs Committee is specifically set up to provide expert advice throughout the EU regulatory process to ensure optimal safety and efficacy of CVD interventions.



Advocacy Committee

Chair

  • Prof. Hugo Katus, FESC, Germany

Members

  • Prof. Victor Aboyans, FESC, France
  • Prof. Riccardo Asteggiano, FESC, Italy - Ex officio Council of Cardio-Oncology
  • Prof. Lina Badimon, FESC, Spain
  • Prof. Enrico Caiani, FESC, Italy – Ex officio Digital Health Committee
  • Prof. dr. Julie De Backer, FESC, Belgium
  • Prof. Paul Dendale, FESC, Belgium
  • Ms. Irene Gibson, Ireland
  • Dr. Alessia Gimelli, Italy
  • Prof. Tomasz Guzik, FESC, United Kingdom – Ex officio Publication Committee
  • Dr. Tina Birgitte Hansen, FESC, Denmark
  • Dr. Mitja Lainščak, FESC, Slovenia
  • Dr. João Morais, FESC, Portugal
  • Ms. Kaat Siebens, FESC, Belgium
  • Prof. Piotr Szymański, FESC, Poland – Ex officio Regulatory Affairs Committee Chair
  • Prof. Miloš Táborský, FESC, Czech Republic
  • Prof. Frans Van de Werf, FESC, Belgium
  • Prof. Panos Vardas, FESC, Greece – Ex officio European Heart Agency
  • Prof. Christiaan Vrints, FESC, Belgium

Advisors

  • Prof. Karin Sipido, FESC, Belgium

 Regulatory Affairs Committee

Chair

  • Prof. Piotr Szymański, FESC, Poland

Members

  • Prof. dr. Thomas Andersen Schmidt, FESC, Denmark
  • Prof. Jacek Bil, FESC, Poland
  • Prof. Giuseppe Boriani, FESC, Italy
  • Prof. Robert Byrne, FESC, Ireland
  • Prof. dr. Ruben Casado, Belgium
  • Prof. Enrico Caiani, FESC, Italy – Ex officio Digital Health Committee
  • Prof. Maja Čikeš, Croatia
  • Prof. Alan Fraser, FESC, United Kingdom
  • Prof. Tina Birgitte Hansen, FESC, Denmark
  • Dr. Fabien Hyafil, FESC, France
  • Prof. Hugo Katus, FESC, Germany – Ex officio Advocacy Committee
  • Dr. Hareld M.C. KEMPS, Netherlands
  • Dr. Vijay Kunadian, FESC, United Kingdom
  • Prof. Martin Landray, FESC, United Kingdom
  • Prof. Aldo Pietro Maggioni, FESC, Italy – Ex officio EURObservational Research Programme
  • Dr. Thomas Modine, France
  • Prof. Giuseppe Rosano, FESC, United Kingdom or Italy
  • Dr. Elisabeth Felicitas Stoll, Germany